Traynor Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-24,350
Closed -$318K 186
2018
Q3
$318K Buy
24,350
+4,250
+21% +$61.4K 0.1% 125
2018
Q2
$303K Buy
+20,100
New +$397K 0.11% 125
2016
Q1
Sell
-16,123
Closed -$1.1M 140
2015
Q4
$1.1M Buy
16,123
+425
+3% +$25.6K 0.79% 30
2015
Q3
$711K Buy
15,698
+9,870
+169% +$575K 0.61% 37
2015
Q2
$306K Buy
+5,828
New +$230K 0.26% 86

Other funds holding PRTA

Traynor Capital Management's PRTA Position: Q4 2018 in Review

Traynor Capital Management sold out of Prothena Corp (PRTA) in Q4 2018, closing a stake of 24,350 shares — an estimated $318K sold.

Traynor Capital Management first reported a position in PRTA in Q2 2015 and held it in 5 quarters. The position peaked at $1.1M in Q4 2015. 120 funds tracked by Wall St. Rank hold PRTA as of Q4 2018.

  • Traynor Capital Management reported no remaining Prothena Corp position as of Q4 2018 after selling out during the quarter.
  • Traynor Capital Management sold 24,350 Prothena Corp shares in Q4 2018, an estimated $318K.
  • Traynor Capital Management first reported a position in Prothena Corp in Q2 2015 and held it in 5 quarters.
  • Traynor Capital Management's Prothena Corp position peaked at $1.1M in Q4 2015.
  • 120 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2018.

Based on Traynor Capital Management's 13F filing for Q4 2018, filed 24 Jan 2019.